August
Why tech bolters are lighting up reporting season
WiseTech, Pro Medicus, Life 360 and REA Group have turned heads this season as tech proves the sweet spot for growth investors again.
Shares slip; Elanor Investors suspended, GYG hits record high
Shares fall 0.2pc. APRA hits ANZ with $250m penalty. Accent Group, Inghams sink on earnings. Telix swings to profit. Latitude’s profit climbs 140pc. Wall St falls. Follow here.
Shares rise; Megaport, Insignia, Collins Foods sink, WiseTech surges
Shares 10 straight days of gains. Whitehaven sells Blackwater stake for $1.6b. Medibank lifts dividends 13.8pc. Insignia pauses dividend. Qube lifts profits 32pc. Follow here.
- Updated
Millennial Zac dumps home ownership dream for ETFs
Zac Shparberg, 30, says he has no hope of owning a property in the city he grew up in. So, he’s embraced a different wealth creation plan that experts say could work.
Miners boost shares; NAB gains, ASX Ltd falls on profit report
Shares add 1.3pc head for six straight sessions of gains. RBA hoses down rate cut hopes. NAB posts flat profit, warns on bad debts. ASX flags record revenue. Follow here.
- Updated
Shares post fifth straight day of gains; Telstra, Magellan lift
Jobless rate climbs to 4.2pc. Iron ore hits lowest since 2022. Telstra ups dividend 5.9pc. Cochlear dividend jumps 24pc. Pilbara Minerals flags acquisition. US inflation eases. Follow here.
China’s bond market flashes more pain for commodity investors
Australia’s status as the lucky country riding Chinese demand for commodities could be threatened by a record-breaking bond yield crash in the world’s second-biggest economy.
ASX rises as Pro Medicus and Seven climb; BHP down 3pc
Shares advance at the closing bell; Commonwealth Bank boosts dividend; Pro Medicus books $82.8 million in net profit; ASIC sues ASX Ltd; iron fall tumbles. Follow here for more.
- Updated
ASX gains but CSL, Seek weigh on disappointing results
Shares edge up; immunoglobulins unit boosts CSL earnings; Seek hit by job ads fall; Orora knocks back Lone Star’s bid; NBN losses deepen. Follow updates here.
- Updated
July
- Opinion
- Sharemarket
Three ASX companies jockeying to be the next biotech winners
Clarity Pharmaceuticals reports it eliminated prostate cancer in a patient; LTR Pharma wants to sell nasal viagra; and Opthea has clinical trial results soon.
Ten books that could help you become a better investor
We asked money managers, financial advisers and a self-made multimillionaire to nominate the books that taught them the most about creating wealth.
Shares fall; Macquarie, Fortescue sink on results
Shares lose 1pc. Seek warns on profits. ANZ suspends, terminates staff. Fortescue misses production expectations. Wall Street tumbles on slowdown worries. Follow here.
ASIC hits ASX pump-and-dump crew with criminal charges
The corporate cop has hit the alleged ring leaders of an ASX penny stock pump and dump scheme with criminal charges that could come with millions in fines.
Global IT chaos triggered by software glitch eases slightly
The impact of what’s being called the most spectacular IT failure the world has ever seen is expected to take at least several days to tally.
- Updated
Chaos across Melbourne as hospitals, airport, supermarkets hit
Shares retreat below 8000 points. APRA relents on Westpac. Lifestyle Communities pulls guidance. Netflix’s profit surges. ECB holds rates. Copper, gold, oil fall. Follow here.
- Updated
Tech sector plunges; traders lift bets on interest rate increase
Jobless rate edges higher in line with expectations, job gains beat forecasts. Domino’s cuts guidance. Telix lifts sales forecasts. Nasdaq posts worst day since 2022. Follow here.
These cheap mining stocks still offer opportunity for investors
A drop in mining business valuations has opened a window of opportunity for investors looking to lock in cheap prices and potentially big dividends.
The ’10-bagger’ stocks that helped push the ASX above 8000
Two blockbuster biotech winners and beneficiaries of investment in the energy transition helped create wealth for savvy investors as shares topped 8000 points.
Should Rio Tinto buy out this ASX lithium miner? Citi thinks so
The investment bank told clients that acquiring Arcadium Lithium could be a more economic option for the iron ore giant than developing its own projects.
Shares hit record high; CBA tops BHP as market’s most valuable company
NAB hits post-GFC high. CBA hits record high. BHP falls. Traders ramp bets on US Fed rate cuts on shock inflation data. Bond yields fall. Citi tips Rio to do lithium deal. Follow here.